Caixin
Aug 21, 2021 08:00 AM

Cspc Innovation Pharmaceutical Co.,Ltd.’s Net Profit Dropped 9.1% in First Half of 2021

Cspc Innovation Pharmaceutical Co.,Ltd. (石药集团新诺威制药股份有限公司) (300765.SZ) reported a net profit of 163.2 million yuan in the first half of 2021, down 9.1% year-on-year.

Meanwhile, the company posted 707.4 million yuan in revenue, up 2.9% year-on-year.

At the end of the reporting period, it had 3.1 billion yuan in total assets and 251.4 million yuan in total liabilities, with a liability-to-asset ratio of 8.2%.

This article was automatically produced by Caixin Automation on Aug. 26, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.

Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST
China Business Uncovered Podcast: Inside the Fall of ‘China’s LVMH’
00:00
00:00/00:00